Finance

Beta
Lists
ALKB:VIE
ALK-Abello A/S
€34.50
-1.48%
(-0.52) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKB...
Open
€34.90
High
€34.90
Low
€34.50
Mkt. cap
52.95B
Avg. vol.
322.00
Volume
0.00
52-wk high
€35.98
52-wk low
€25.92
No. of employees
3K
Open
€34.90
High
€34.90
Low
€34.50
Mkt. cap
52.95B
Avg. vol.
322.00
Volume
0.00
52-wk high
€35.98
52-wk low
€25.92
No. of employees
3K
News stories
From sources across the web
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.76K
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitealk.net
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.53B
1.53B
1.73B
1.77B
Cost of goods sold
532.00M
487.00M
543.00M
543.00M
Cost of revenue
532.00M
487.00M
543.00M
543.00M
Research and development expenses
146.00M
145.00M
189.00M
151.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
474.00M
475.00M
605.00M
507.00M
Operating expense
620.00M
620.00M
793.00M
658.00M
Total operating expenses
1.15B
1.11B
1.34B
1.20B
Operating income
375.00M
423.00M
397.00M
570.00M
Other non operating income
-
-
-
-
EBT including unusual items
350.00M
419.00M
393.00M
583.00M
EBT excluding unusual items
350.00M
419.00M
403.00M
583.00M
Income tax expense
87.00M
105.00M
127.00M
146.00M
Effective tax rate
24.86%
25.06%
32.32%
25.04%
Other operating expenses
-
-
-1.00M
-
Net income
263.00M
314.00M
266.00M
437.00M
Net profit margin
17.22%
20.52%
15.35%
24.68%
Earnings per share
-
1.40
1.20
-
Interest and investment income
-
-
28.00M
13.00M
Interest expense
-25.00M
-4.00M
-6.00M
-
Net interest expenses
-25.00M
-4.00M
22.00M
13.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
450.00M
510.00M
400.00M
654.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer